Board of Directors
Jonas Ekblom has over 25 years of experience from pharmaceutical R&D. Dr. Ekblom has held senior positions at Pharmacia, Sequenom, Life Technologies, and BOWS Pharmaceuticals. Dr. Ekblom is the CEO of Promore Pharma AB. Jonas Ekblom also serves of the board of several other organizations including EffRx Pharmaceuticals SA, Med-C, and The Releef Initiative.
Magnus Axelson, co-founder of Axelar AB, is Professor at the Department of Clinical Chemistry, Karolinska Institutet/Hospital, Stockholm and has over 40 years of research experience. Professor Axelson’s research has primarily focused on the structure and biological activity of small molecules, particularly steroids, lignans, and congeners.
Fredrik Gilstring represents the Gilstring Family. He currently works for Gustavia Fonder AB as a portfolio manager and has more than 7 years’ of investment experience in the life science industry. He has a background as senior scientist in the field of cell and molecular biology at Karolinska Institute, Sweden. From 2002-2008 he was employed as project manager at Sidec AB, a contract research organization (CRO) involved in performing protein structure analysis using electron tomography.
Gillis Cullin represents the Foundation for Baltic and East European Studies and has experience of executive roles among others deputy executive director in Praktikertjänst and executive director in Praktikerinvest. He is today working as a senior advisor to some companies and is also a director of some boards. He is chairman of nomination committe of two stock exchange companies Victoria Park and Moberg Pharma.
Alternate Board Member
Mattias Klintemar represents the Foundation for Baltic and East European Studies and has extensive experience of C-suite roles in the Finance and Technology sectors, among others as Group CEO at Morphic Technologies, CFO at Hexaformer, senior corporate finance associate at ABG Sundal Collier and auditor at Arthur Andersen. He is also chairman of the board in Dilafor and member of the board of directors also in Moberg Pharma, Oatly and Phoniro, as well as chairman of the nomination committee of Lightlab, Pharmanest and Cellimpact.
Alternate Board Member
Olle Larsson, co-founder of Axelar AB, is Professor at the Department of Oncology-Pathology, Karolinska Institutet, Stockholm